Improved GaLV-TR Glycoproteins to Pseudotype Lentiviral Vectors: Impact of Viral Protease Activity in the Production of LV Pseudotypes
Lentiviral vectors (LVs) are excellent tools for gene transfer into mammalian cells. It is noteworthy that the first gene therapy treatment using LVs was approved for commercialization in 2017. The G glycoprotein from rhabdovirus vesicular stomatitis virus (VSV-G) is the glycoprotein most used to ps...
Guardat en:
| Autors principals: | , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Elsevier
2019-12-01
|
| Col·lecció: | Molecular Therapy: Methods & Clinical Development |
| Accés en línia: | http://www.sciencedirect.com/science/article/pii/S2329050119300804 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|